Peptides as Potential Therapeutics for Alzheimer’s Disease

Author： Ribarič Samo  

Publisher： MDPI

E-ISSN： 1420-3049|23|2|283-283

ISSN： 1420-3049

Source： Molecules, Vol.23, Iss.2, 2018-01, pp. : 283-283

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease

By Jones Mike   Wang Jun   Harmon Shona   Kling Beata   Heilmann Jörg   Gilmer John F.  

Molecules, Vol. 21, Iss. 4, 2016-04 ,pp. : 440-440

MDPI

Access to resources Recommend Favorite

Potential Neuroprotective Effects of Adiponectin in Alzheimer’s Disease

By Ng Roy Chun-Laam   Chan Koon-Ho  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 592-592

MDPI

Access to resources Recommend Favorite

Melatonin in Alzheimer’s Disease

By Lin Li   Huang Qiong-Xia   Yang Shu-Sheng   Chu Jiang   Wang Jian-Zhi   Tian Qing  

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 14575-14593

MDPI

Access to resources Recommend Favorite

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

By Kosicek Marko   Hecimovic Silva  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 1310-1322

MDPI

Access to resources Recommend Favorite

Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease

By Cacciatore Ivana   Marinelli Lisa   Fornasari Erika   Cerasa Laura S.   Eusepi Piera   Türkez Hasan   Pomilio Cristina   Reale Marcella   D’Angelo Chiara   Costantini Erica   Di Stefano Antonio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1035-1035

MDPI

Access to resources Recommend Favorite